Form 4 for KROS Keros Therapeutics, Inc.
Accepted 2022-04-08 00:00:00 ET · period of report 2022-04-06 · accession 0001209191-22-023860 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-08 | 2022-04-06 | KROS | Rovaldi Christopher | COO | S - Sale+OE | $65.00 | -1,728 | 0 | -100% | -$112.3K |
| D | 2022-04-08 | 2022-04-06 | KROS | Rovaldi Christopher | COO | M - OptEx | $16.00 | +1,728 | 1,728 | New | +$27.6K |
| D | 2022-04-08 | 2022-04-06 | KROS | Rovaldi Christopher | COO | M - OptEx | $0.00 | -1,728 | 8,002 | -18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-06 | S | D | 1,728 | $65.00 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-06 | M | A | 1,728 | $16.00 | 1,728 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2022-04-06 | M | D | 1,728 | $0.00 | 8,002 | D | $16.00 · — to 2030-04-07 | 1,728 Common Stock | (F2) One-fourth (1/4th) of the shares subject to the option vested on January 1, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. |